Director - Targeted Protein Degradation

Direct the Targeted Protein Degradation initiative within Amgen's IPP, defining and executing a bold scientific vision to expand the degrader platform, build next-generation capabilities, establish strategic partnerships, and translate cutting-edge biology into transformative medicines. Lead, mentor, and develop a multidisciplinary team spanning chemical biology, proteomics, chemistry, and translational sciences; drive strategic execution of discovery programs, identify high-value opportunities, and incorporate AI/data-driven approaches to improve target identification, ligand discovery, and prediction of therapeutic outcomes. Shape platform strategy, foster collaboration with Therapeutic Areas and Development, and communicate a compelling vision to scientifically engage internal and external audiences while maintaining high scientific rigor and collaboration across functions.